BioSpace News Archive

As Deadliest Strain Ravages Country, Four Experimental Ebola Vaccines to Be Deployed in the Congo

As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.

November 12, 2018
·
3 min read
·
Alex Keown
Drug Development

Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game

Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.

November 12, 2018
·
10 min read
·
Chelsea Weidman Burke
Lamellar to introduce its LAMELLASOME™ technology for the safe and effective delivery of nucleic acid based therapeutics at BIO-Europe 2018 in Copenhagen

Lamellar Biomedical Limited announces that Dr Alec McLean ,CEO, Dr Lynsey Howard (Head of Preclinical) and Steven Porteous (Head of Clinical and Regulatory) will be attending BIO-Europe 2018 in Copenhagen to introduce potential partners and investors to its cutting-edge LAMELLASOME™ technology.

November 12, 2018
·
3 min read
Drug Development

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP

Met primary endpoint of Early Clinical Response at 96 hours after the first dose

November 12, 2018
·
13 min read
Drug Development

THERANEXUS ANNOUNCES INCLUSION OF LAST PATIENT IN PHASE II TRIAL OF DRUG CANDIDATE THN102 ON NARCOLEPSY PATIENTS

Theranexus announces today that it has recruited the last patient in its Phase II trial, entitled “Tolerance and Efficacy of THN102 on Sleepiness in Narcoleptic Patients”.

November 12, 2018
·
2 min read
Business

OncoDNA is pleased to announce collaboration in the MDLUX2 program from INC (National Cancer Institute), Molecular Diagnostics Program funded by IBBL (Integrated BioBank of Luxembourg), the Fondation Cancer and the Fondatioun Kriibskrank Kanner

Molecular diagnostic programme for better cancer treatment kicks off

November 12, 2018
·
5 min read
Genetown

TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen

TESARO, Inc. today announced the achievement of development milestones that trigger an $18 million payment from Janssen Biotech Inc. (Janssen).

November 12, 2018
·
4 min read
IVI MIDDLE EAST FERTILITY CLINIC IN MUSCAT UNVEILS LIMITED SPECIAL OFFER TO CELEBRATE OMANI WOMEN’S DAY

In commemoration of Omani Women’s Day (Wednesday, October 17, 2018), IVI Middle East Fertility Clinic in Muscat has unveiled a special offer paying tribute to women and their important role in nation building.

November 12, 2018
·
1 min read
Deals

Lonza Acquires a Controlling Stake in Octane Biotech to Further Develop CocoonTM Autologous Technology

Acquisition further strengthens Lonza’s commitment to drive the next generation of manufacturing patient-specific and personalized therapies

November 12, 2018
·
4 min read
LUCENCE DIAGNOSTICS LAUNCHES WORLD’S FIRST MOLECULAR TEST TO GUIDE SURGICAL APPROACH FOR BREAST FIBROEPITHELIAL TUMORS

Lucence Diagnostics today announced the launch of the world’s first molecular test to distinguish breast fibroadenoma, the commonest benign breast tumor, from phyllodes tumor, a less common tumor that may be malignant.

November 12, 2018
·
6 min read